Globus Medical Announces First Case in Orthopedic Trauma
September 14 2017 - 4:15PM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, today announced it completed its first
orthopedic trauma surgical case. Globus Medical’s new ANTHEM™
Distal Radius Fracture System was used by Dr. Asif Ilyas, Hand
Surgeon and Trauma Surgeon with The Rothman Institute at Thomas
Jefferson University in Philadelphia PA, to successfully treat a
distal radius fracture.
The ANTHEM™ Distal Radius Fracture System is a
comprehensive fixation system designed to treat a variety of
traumatic wrist fractures with anatomically contoured plates for
intraoperative versatility. “This is the first orthopedic trauma
surgery performed using a plating system designed, manufactured and
sold by Globus Medical,” said Barclay Davis, Vice President,
Orthopedic Trauma. “We are very proud to continue Globus’
reputation for innovation, speed to market, and listening to our
surgeon customers, by bringing this philosophy to the orthopedic
trauma market. This introduction is the culmination of a
significant effort between Globus Medical’s outstanding product
development team and leading orthopedic trauma surgeons. And there
are many more to come.”
The innovative ANTHEM™ plate design allows a
clear view of the fracture line for improved diagnosis and care.
“This plate features a positioning slot and screw that allows
multidirectional fine tuning of plate position to provide surgeons
maximum flexibility during surgery. I am impressed by how intuitive
the tray and system are and how natural the instrumentation feels.
The implant was seamless in its placement and fixation,” said Dr.
Asif Ilyas. “Trauma is a large, busy, and complex space. That space
is ready for a company like Globus to take our current designs and
technology and advance them to the next level."
Globus Medical is planning to introduce its new
orthopedic trauma product line at the Orthopaedic Trauma
Association's 33rd Annual Meeting to be held October 11-14, 2017 in
Vancouver, Canada.
Indications The ANTHEM™
Fracture System is indicated for fixation of fractures,
osteotomies, arthrodesis and reconstruction of bones for the
appropriate size of the device to be used in adult patients,
including the clavicle, scapula, humerus, radius, ulna, small bones
(metacarpals, metatarsals, phalanges), wrist, pelvis, femur, tibia,
fibula, ankle, and foot. Small fragment and distal fibula plates
may be used in all pediatric subgroups (except neonates) and small
stature adults. Distal radius plates may be used in adolescents
(12-21 years of age).
About Globus Medical,
Inc.Globus Medical, Inc. is a leading musculoskeletal
solutions company based in Audubon, PA. The company was
founded in 2003 by an experienced team of professionals with a
shared vision to create products that enable surgeons to promote
healing in patients with musculoskeletal disorders.
Safe Harbor Statements All statements
included in this press release other than statements of historical
fact are forward-looking statements and may be identified by their
use of words such as “believe,” “may,” “might,” “could,” “will,”
“aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,”
“plan” and other similar terms. These forward-looking
statements are based on our current assumptions, expectations and
estimates of future events and trends. Forward-looking
statements are only predictions and are subject to many risks,
uncertainties and other factors that may affect our businesses and
operations and could cause actual results to differ materially from
those predicted. These risks and uncertainties include, but
are not limited to, factors affecting our quarterly results, our
ability to manage our growth, our ability to sustain our
profitability, demand for our products, our ability to compete
successfully (including without limitation our ability to convince
surgeons to use our products and our ability to attract and retain
sales and other personnel), our ability to rapidly develop and
introduce new products, our ability to develop and execute on
successful business strategies, our ability to successfully
integrate the international operations acquired from Alphatec, both
in general and on our anticipated timeline, our ability to
transition Alphatec’s international customers to Globus Medical
products, our ability to realize the expected benefits to our
results from the Alphatec acquisition, our ability to comply with
laws and regulations that are or may become applicable to our
businesses, our ability to safeguard our intellectual property, our
success in defending legal proceedings brought against us, trends
in the medical device industry, general economic conditions, and
other risks. For a discussion of these and other risks,
uncertainties and other factors that could affect our results, you
should refer to the disclosure contained in our most recent annual
report on Form 10-K filed with the Securities and Exchange
Commission, including the sections labeled “Risk Factors” and
“Cautionary Note Concerning Forward-Looking Statements,” and in our
Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at
www.sec.gov. Moreover, we operate in an evolving
environment. New risk factors and uncertainties emerge from
time to time and it is not possible for us to predict all risk
factors and uncertainties, nor can we assess the impact of all
factors on our business or the extent to which any factor, or
combination of factors, may cause actual results to differ
materially from those contained in any forward-looking
statements. Given these risks and uncertainties, readers are
cautioned not to place undue reliance on any forward-looking
statements. Forward-looking statements contained in this
press release speak only as of the date of this press
release. We undertake no obligation to update any
forward-looking statements as a result of new information, events
or circumstances or other factors arising or coming to our
attention after the date hereof.
Contact:Daniel ScavillaSenior
Vice President, Chief Financial OfficerPhone: (610) 930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2023 to Apr 2024